Dr. Neeraj Agarwal
Professor of Medicine and Senior Director for Clinical Research Innovation at Huntsman Cancer Institute (HCI)
Dr. Kim Chi
Medical Oncologist and the Chief Medical Officer at BC Cancer, British Columbia, Canada. He is also a Professor of Medicine at the University of British Columbia, and past Chair of the Genitourinary Disease Site Committee for the Canadian Cancer Trials Group (CCTG).
Dr. Bishoy Faltas
Director of Bladder Cancer Research at the Englander Institute of Precision Medicine Institute at Weill-Cornell. He is an Assistant Professor of Medicine, Cell, and Developmental Biology. He is also the Gellert Family-John P. Leonard, MD Research Scholar in Hematology and Medical Oncology.
Dr. Karim Fizazi
Medical Oncologist at Institute Gustave Roussy and Full Professor in Oncology at the University of Paris Saclay in Villejuif, France. He is the President of the French Groupe d’Etude des Tumeurs Genito-Urinaires (GETUG) and Associate Editor of European Journal of Cancer.
Dr. Shilpa Gupta
Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Ohio, USA. She serves on the ASCO Annual Scientific Committee for Genitourinary Cancers and SITC Anti-PD-1/PD-L1 Resistance Task Force.
Dr. Daniel Heng
Section Chief of Medical Oncology and Staff Medical Oncologist at the Tom Baker Cancer Center in Calgary, Alberta and a Clinical Professor of Medicine at the University of Calgary. He is the Chair of the International mRCC Database Consortium which includes over 40 cancer centers worldwide.
Dr. Maha Hussain
Genevieve Teuton Professor of Medicine in the Division of Hematology-Oncology, Department of Medicine, and the Deputy Director, and leader of the GU Oncology Program at the Robert H. Lurie Comprehensive Cancer Center of the Northwestern University Feinberg School of Medicine, Chicago, USA.
Dr. Joseph Kim
A Board-Certified Medical Oncologist and an Associate Professor of Medicine at Yale School of Medicine in New Haven, Connecticut, USA. He specializes in genitourinary cancers and early phase drug development clinical trials.
Dr. Christian Kollmannsberger
Staff Medical Oncologist at the British Columbia Cancer Agency (BCCA) Vancouver Cancer Centre and Clinical Professor at the University of British Columbia. He serves as Chair of the BC Cancer Provincial Genitourinary Tumor Group, Chair for the Genitourinary Systemic Therapy Clinical Trials Unit at BC Cancer Vancouver Centre, and Chair for the Canadian Clinical Trials Group Testis Cancer Disease Oriented Group.
Dr. Sumanta Pal
An internationally recognized leader in the area of genitourinary cancers, including kidney, bladder, and prostate cancer. He is a Clinical Professor at the City of Hope Comprehensive Cancer Center and Co-Director of the institution’s Kidney Cancer Program, California, USA.
Dr. Camillo Porta
Chair of Oncology Department of Biomedical Sciences and Human Oncology at University of Bari 'A. Moro' And Chief of Division of Medical Oncology at Policlinico Consorziale di Bari, Italy. He is also an Associate Professor, Department of Internal Medicine and Therapeutics at the University of Pavia, Italy.
Dr. Thomas Powles
Professor of Urology Cancer at the University of London and the Director of Barts Cancer Centre, UK. He trained as in Oncologist at Imperial College. He leads the ESMO guidelines for renal and bladder cancer and is the track chair for non-prostate GU cancer in 2021 (Paris).
Dr. Brian Rini
Chief of Clinical Trials at Vanderbilt-Ingram Cancer Center and Ingram Professor of Medicine at Vanderbilt University, Tennessee, USA where he leads kidney cancer clinical research efforts and the expansion of cancer clinical research operations. He is a member of ASCO, KCA (Kidney Cancer Association) and SITC (Society for Immunotherapy of Cancer) with leadership positions in these organizations.
Dr. Fred Saad
Professor and Chairman of Urology and Director of Genitourinary Oncology at the University of Montreal Hospital Center (CHUM), in Montreal, QC, Canada. He holds the Raymond Garneau Chair in Prostate Cancer Research and is Director of Clinical Research and the Molecular Oncology Research Laboratory in Prostate Cancer.
Dr. Fernando Sabino
Medical Oncology at Centro de Oncologia e Hematologia do Hospital Santa Lúcia Hospital Universitário de Brasilia/UNB, Brasília, Distrito Federal, Brazil, USA.